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　Extensive studies on the IL-2 and IL-2 receptor system have established fundamental 
principles of immune responses and signal transducing mechanisms of hematopoietic 
cell proliferation and survival. IL-2Rb and IL-2Rg chains are associated with multiple 
tyrosine kinases including JAK1, JAK3 and other tyrosine kinases such a p56lck. IL-2 
binding to these receptors leads to conformational changes of the receptors followed by 
the recruitment of several kinases leading to their activation. The JAKs and activated 
tyrosine kinases appear to be a trigger for the downstream signal cascades. Other 
downstream messenger molecules such as the STATs, Shc, PI3K-Akt, Ras-ERK1/2 and 
so on, cross talk with this cascades. The interplay however leading to the regulation of 
target genes still remain largely obscure. For example, although phosphorylation of 
tyrosine 338 of IL-2Rb is required for both signal transduction to Shc and PI3K, how it 
regulates further signals from Shc to the Grb2-Sos-Ras pathway or to the PI3K-Akt 
pathway is unknown. There are also conflicting reports on the functional roles of 
STAT5, STAT1 and STAT3 on IL-2 signaling. Further work is needed to clarify how the 
multiple kinases trigger multiple signaling cascades and cooperate with each other in 
the regulation of gene induction for cell growth, survival or differentiation in different 
cell types and conditions in vitro and also in vivo.
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many other soluble mediators, play a pivotal 
role in the development and regulation of the 
immune system. Interleukin 2 (IL-2) is one of 
the earlier discovered cytokines secreted by 
INTRODUCTION
　Cytokines, which include interleukins and 
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activated peripheral blood lymphocytes and 
shown to promote T lymphocyte expansion1). 
IL-2 is also known to activate lymphokine-
activated killer (LAK), cytotoxic T lymphocyte 
(CTL) activity, and to promote B lymphocyte 
proliferation and immunoglobulin secretion2).
　IL-2 binds to target cells through its 
receptors expressed on the cell surface and 
transduces its signals into the cells. IL-2 
receptor (IL-2R) consists of three distinct 
subunits, IL-2Rα chain (IL-2Rα), IL-2Rβ 
chain (IL-2Rβ) and IL-2Rγ chain (IL-2Rγ)3)-7).
IL-2 forms a heterotrimer with these receptors 
and this heteromerization provokes tyrosine 
phosphorylation of these receptors8)-11), which is 
thought to be a first event in the intracellular 
signal transduction. Importantly these recep-
tors have no intrinsic kinase activity, unlike 
classical growth factor receptors such as 
epidermal growth factor receptor (EGF-R) and 
pletelet derived growth factor receptor (PDGF-
R). Because of vigorous studies to identify the 
kinases catalyzing such protein phosphory-
lation especially on tyrosine residues, many 
kinds of tyrosine kinases were found to be 
involved in the IL-2 signaling system12).
　Here we will discuss the mechanisms of 
signal transduction from the IL-2Rs to the 
nucleus through multiple tyrosine kinase 
concerted systems.
IL-2 receptors
　IL-2Rα (CD25) is a type I membrane 
protein whose molecular weight is 55 kD. IL-
2Rα has only 13 amino acids in its cytoplasmic 
region. However IL-2 binds to IL-2Rα with 
low affinity (Kd: 10 nM), and is thought to 
have no function on the intracellular signal 
transduction13). The expression of IL-2Rα is 
tightly restricted on peripheral activated T and 
B cell, triple negative thymocytes and bone 
marrow pre-B cells. The most important 
function of IL-2Rα is forming a functional 
high affinity (Kd: 10 pM) receptor on these 
cells together with IL-2Rβ and IL-2Rγ2) 
(Fig.1). IL-2Rβ (CD122) and IL-2Rγ (CD132) 
are also type I membrane proteins whose 
molecular weight is 75 kD and 64 kD 
respectively, and belong to the cytokine 
receptor family which is characterized by the 
presence of a cytokine receptor domain of 
about 210 amino acids in the extracellular 
region14),15). This domain is separated by two 
homologous type III fibronectin subdomains. 
The first subdomain is characterized by the 
presence of two pairs of cysteine residues at 
the N-terminal part, and the second subdo-
main has a consensus tryptophan-serine-X-
tryptophan-serine motif (WS motif). The 
heterodimer composed of IL-2Rβ and IL-2Rγ 
can bind to IL-2 with intermediate affinity 
(1nM) and both receptors are necessary for a 
functional IL-2 receptor complex16)-20). Cytokine 
receptor family members are also character-
ized by the absence of intrinsic tyrosine kinase 
activity. Which kinases phosphorylate the 
different intracellular proteins and transduce 
downstream signals after IL-2 binding to its 
receptor?
The JAK (Janus tyrosine kinase) family 
protein tyrosine kinases
　Four members of the JAK family kinases, 
JAK1, JAK2, JAK3 and Tyk2, were found as 
non-receptor type tyrosine kinases in the 
mammalian system. Many reports showed that 
these family members are deeply involved in 
the signal transduction from all cytokine 
receptors21). JAK1 and JAK3 were phosphory-
lated on tyrosine residue after IL-2 treatment, 
and were reported to be associated with IL-
2Rβ and IL-2Rγ respectively in an IL-2-inde-
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pendent manner22)-27) (Fig.1). The JAK associa-
tion sites on these receptors are the S-region, 
including the Box1 of IL-2Rβ , and the portion 
from amino acid 38 through 56 of the 
intracytoplasmic region of IL-2Rγ.
　The indispensability of the JAK-associated 
region for IL-2-induced cell proliferation 
signaling, was shown with experiments using 
deletion mutants of IL-2Rβ and IL-2Rγ. 
However, a mutation of Box1 in the IL-2Rβ 
can transduce IL-2-induced cell proliferation 
signals together with wild type IL-2Rγ in a T 
cell line, although the mutant IL-2Rβ cannot 
bind nor activate JAK128). Migone, et al. 
reported that JAK1 is important for the 
efficient recruitment of the p85 molecule of 
phosphatidylinositol 3-kinase (PI3Kp85) to IL-
2Rβ29). In addition PMA-stimulated thymo-
cytes from JAK1-deficient mice showed a 
reduced response to IL-2 30). Taken together 
these results indicate that there may be two 
pathways of IL-2-induced signaling; JAK1 
dependent and JAK1 independent.
　Miyazaki, et al. reported JAK3 is required 
for the IL-2-induced DNA synthesis in NIH-
3T3 cell expressing IL-2Ra, β and γ, since 
JAK3 is not expressed in the parent cells27). 
Furthermore a dominant negative form of 
JAK3, whose kinase domain was deleted, 
inhibited IL-2-induced JAK1 activation, c-fos 
and c-myc gene induction, and IL-2-dependent 
cell growth, but not bcl2 induction31). On the 
other hand, Nelson, et al. demonstrated that 
not only JAK3 activation, but also the 
membrane proximal domain of IL-2Rγ is 
indispensable for IL-2-induced T cell growth 
　Fig.1. IL-2-induced tyrosine phosphorylation of IL-2 receptor β chain.
IL-2 binding to IL-2 receptor complex, induces activation of many types of tyrosine kinases followed 
by tyrosine phosphorylation of the receptors. Phosphorylated tyrosine residues recruit second 
messengers like Shc, PI-3K and STATs. Cysteine repeat and WS motif on type III fibronectin 
subdomain homology of IL-2Rβ are indicated as c-c and WS, respectively. S, A and H regions of IL-
2Rβ are indicated as S, A and H, respectively.
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signals32). Tsujino, et al. showed that a C-
terminal deletion mutant of IL-2Rγ, which 
cannot associate with JAK3, still activated 
JAK1 and STATs, and phosphorylated 
PI3Kp8533). These results suggest the existence 
of a JAK3 independent signaling pathways.
　JAK3 gene targeted mice had no NK cells, a 
drastic reduction in thymocytes and showed a 
severe block in B cell development at the pre-B 
stage in the bone marrow, in addition to having 
functionally deficient residual T and B 
cells34)-36). Although these phenotypes were 
similar to that of IL-2Rγ-deficient mice 37)-39), 
they are not thought to be due to the deficiency 
of IL-2, but rather due to IL-7, IL-15 or IL-21 
signaling that are also using the IL-2Rγ-JAK3 
system40)-43). It is clear that these JAKs are the 
key enzymes for the downstream signaling 
events. After IL-2 binding to its receptor, the 
conformation of heterodimer or heterotrimer 
receptor is changed and these JAKs might be 
close to each other and become cross-activated. 
How do activated JAKs transduce signals?
STAT (Signal Transducer and Activator 
of Transcription) family
　All the cytokine receptor family members 
activate JAKs after cytokine binding. STATs 
are thought to be major signaling molecules 
which are in the downstream of activated 
JAKs44). Activated JAKs phosphorylate tyrosine 
residues on its receptor itself. STATs are 
thought to recognize phosphotyrosine on the 
receptor through its SH2 domain. Recruited 
STATs on the receptor are tyrosine phosphory-
lated on the C-terminal part by JAKs then 
separate from the receptor and form a homo or 
heterodimer complex via reciprocal interac-
tions between their SH2 domains. Dimerized 
STATs are further phosphorylated on serine 
residue by serine/threonine kinases and 
become maximally activated. Finally, activated 
STATs translocate to the nucleus and function 
as transcriptional factors.
　In the IL-2 system, STAT5 is mainly 
activated after stimulation45)-54) (Fig.1). Fried-
mann, et al. reported tyrosine 338, 392 and 510 
of IL-2Rβ were phosphorylated after IL-2 
binding55). IL-2Rβ mutants in which tyrosine 
392 and 510 were replaced by phenylalanine, 
could not activate STAT5 and reduced IL-2-
induced 32D mouse myeloid cells proliferation. 
In contrast to this, BaF-B03 mouse pro-B cells 
expressing the IL-2Rβ mutant deleted of the 
C-terminal half including STAT5 binding sites 
(tyrosine 392 and 510), proliferate in response 
to IL-2 without activation of STAT5 just as 
well as IL-2Rβ wild type expressing cells47). By 
using dominant-negative forms of STAT5, 
STAT5 was shown to participate in IL-3-
dependent proliferation56), 57). They also showed 
cis, osm, pim-1 and cyclin D1 as the target 
genes of STAT5. To investigate the function of 
STAT5 directly, Onishi, et al. screened 
randomly mutated STAT5 which can maintain 
IL-3-dependent Ba/F3 cells without IL-3 58). 
They identified constitutive active types of 
STAT5 which induce cytokine independent 
growth of Ba/F3. In this active form of STAT5 
expressing cells, pim-1, bcl-x and c-myc are 
upregulated without IL-3 59). Interestingly, IL-3 
treatment to these cells leads to differentiation 
and apoptosis accompanied with strong 
induction of JAB, CIS and p21WAF1/Cip1. 
These results suggest STAT5 activity may 
regulate cell fate through the control of the 
target genes expressions (Fig.2).
　There are two genes highly conserved for 
STAT5, STAT5a and STAT5b. Teglund, et al. 
established STAT5a and b-double-deficient 
mice, and noticed that the lymphoid develop-
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ment is normal 60). Anti-CD3 antibody-induced 
cell proliferation of peripheral T cell from 
STAT5a/b deficient mice is profoundly reduced 
in the presence or absence of IL-2 or IL-4 61), 62). 
So STAT5 seems to have an essential role in IL-
2 and IL-4-induced T cell proliferation through 
some cell cycle regulating genes like p27Kip1, 
cyclin D2, D3, E, A and cdk6. However, there 
are also conflicting results with the phenotypes 
of STAT5a/b deficient mice. Fujii, et al. 
established mutants IL-2Rb transgenic mice 
on the IL-2Rβ null background 63). When IL-
2Rβ mutants lacking STAT5 binding sites (H-
region) were transgened, spleen cells could not 
induce IL-2R α expression, but however 
responded to IL-2 normally without activation 
of STAT5 after TCR cross-linking with anti-
CD3 antibody. Furthermore, by using a 
retroviral transfection system, Van Parijs, et al. 
reconstituted mutant IL-2Rβ into the periph-
eral T cells of IL-2Rβ deficient mice, and 
clearly demonstrated either H-region or 
tyrosine 338 where is in A-region of IL-2Rβ is 
required for the IL-2-induced T cell prolifera-
tion after TCR cross-linking 64)(Fig.1). The 
functional role of STAT5 for cell proliferation 
seems to be important but not indispensable 
and they show STAT5 is not required for cell 
survival. Taken together, it is unclear why T 
cells from STAT5a/b deficient mice cannot 
respond to IL-2 at all. One possible explanation 
is that STAT5 may have some indispensable 
role in the maintenance of essential compo-
nents of the IL-2/IL-2R system. For example, 
in the case of STAT1, basal expression of 
STAT1 is required for the maintenance of 
caspase expression65). Another explanation is 
the impairment of not only IL-2/IL-2R system, 
but also TCR signaling in the STAT5a/b 
deficient mouse because STAT5 is reported to 
be involved in TCR signaling in mouse D10 cell 
line 66). The duration of transient expression of 
IL-2R α in TCR-stimulated T cells from 
STAT5a/b deficient mice is much shorter than 
that of T cells from wild type mice 62). However, 
this is not the reason why STAT5a/b deficient 
T cells lose their response to IL-2, as IL-2Rα 
overexpressed STAT5a/b deficient T cells still 
show no proliferative response to IL-2 64). 
Further analysis seems to be necessary to 
explain the functional significance of STAT5 in 
the T cell proliferation through the TCR and 
IL-2/IL-2R system.
　Unique functions of IL-2 in vivo are the 
termination of T cell activation and mainte-
nance of tolerance. Fas/Fas L system is though 
to be the main machinery of activation-induced 
cell death of activated T cells. Van Parijs, et al. 
also showed STAT5 activation is necessary for 
the induction of Fas L and activation-induced 
cell death64). These results raise another 
question of how IL-2 regulates T cell activation 
and T cell death through the same pathway.
　Besides STAT5, IL-2 activates STAT1 and 
STAT3, and recent reports showed that STAT1 
and STAT3 are associated through the acidic 
region (A-region) of IL-2Rβ which is a 
different portion from the STAT5 binding 
site67) (Fig.2). Akaishi, et al. demonstrated that 
IL-2-induced IL-2Rα induction was impaired 
in peripheral T cell from T cell specific STAT3 
deficient mice 68). The functional roles of STAT1 
in IL-2/IL-2R system are unclear.
　STATs activities are secondary regulated 
with serine phosphorylation44). Some reports 
show serine/threonine kinases as the candi-
dates which catalyze this phosphorylation; 
ERK1/2 for STAT5 69), mTOR for STAT3 70) and 
p38MAPK for STAT1 71). ERK1/2 is also 
reported to be an inhibitor of STAT3 72), 73). In 
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　Fig.2. IL-2-induced signaling network.
Molecules thought to be involved in the IL-2 signaling network and some regulated genes which are 
related to cell proliferation and survival are shown.
Asao
contrast with this, another report suggests 
ERK1/2 is not a kinase for STAT5 74). The 
entire network of STATs activation is still 
obscure.
p52shc
　Several cytokines including EGF and PDGF 
activate Ras and its downstream signal 
transducer ERK1/2. Burns, et al. showed IL-2 
induces tyrosine phosphorylation of p52shc 
adaptor protein in T cells 75). Later Shc is 
demonstrated to be associated with IL-2Rβ 
through phosphorylated tyrosine 338 and PTB 
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domain of Shc 55), 76) (Fig.1). Phosphorylated Shc 
is thought to recruit Grb2 and induces a 
downstream cascade involving Sos, Ras, Raf 
and ERK1/2 77), 78). Finally ERK1/2 translocates 
to the nucleus and participates in the induction 
of genes such as c-fos. p56lck is the first 
identified tyrosine kinase associated with the 
IL-2R 79). p56lck is associated with the A-region 
of IL-2Rβ and p56lck activation leads to the 
induction of c-fos and c-jun 80), 81). However, the 
relationship between the Shc-Grb2 pathway 
and p56lck pathway is unclear. Lord, et al. 
reported that Shc activation is enough to 
activate MAP kinase, induce c-fos and c-myc 
genes and promote cell proliferation with 
chimeric receptor of IL-2Rβ proximal region 
and Sch fusion protein 82). They also showed 
that the chimera receptor can induce cell 
survival regulator genes, bcl-2 and bcl-x, but 
this activity is not sufficient to sustain the long-
term cell viability. What molecules besides the 
Ras-ERK1/2 pathway, are in the downstream 
of Shc to regulate the bcl-2 and bcl-x should be 
clear.
Phosphatidylinositol 3-kinase (PI3K)-Akt 
pathway
　IL-2 is well known to activatePI3K 83)-85). 
Later Akt (serine/threonine protein kinase B 
(PKB)) was reported to be at the downstream 
of PI3K 86). Akt activity is thought to play 
important roles in many cytokine and growth 
factor-induced cell survival. Van Parijs, et al. 
showed Akt phosphorylation is dependent on 
tyrosine 338 of IL-2Rβ which is the same 
interaction site of Shc, and signal through 
tyrosine 338 of IL-2Rβ is sufficient for T cell 
growth and survival 63). PI3K-Akt cascade may 
interact with the tyrosine 338 directly and 
transduce T cell survival signals instead of Shc. 
This model is supported by the data that a 
catalytically active Akt partially protects cells 
from IL-3-withdrawal-induced apoptosis and 
promotes cell cycle progression87). They also 
showed c-myc and bcl2 are constitutively 
upregulated in the active Akt expressing cells. 
On the other hand, E2F, the key molecule in 
the cell cycle, is activated with IL-2 88). By using 
a transient reporter assay, they showed IL-2-
induced E2F activation is blocked with 
dominant negative mutant forms of PI3K or 
the PI3K inhibitor, LY294002. LY294002 also 
inhibited IL-2-mediated induction of cyclin D3 
gene and down-regulation of p27kip1. In this 
way, IL-2 may induce phosphorylation of Rb 
and p130, activate E2F and progress cell cycle 
at least through PI3K-Akt pathway.
　Another pathway for cell survival through 
Akt is that involving BAD phosphorylation. 
Akt is reported to phosphorylate BAD, which 
belongs to Bcl2 family and induces apopto-
sis89),90). Phosphorylated BAD by Akt is inac-
tivated and cells are protected from apoptosis. 
However the conclusion of Akt as a BAD 
kinase is arguable because BAD kinase could 
be different from Akt, for example MEK-
ERK1/2 pathway, and responsible kinases in 
BAD phosphorylation may be dependent on 
individual cytokines 91). These results suggest 
PI3K-Akt pathway may contribute to IL-2-
induced cell cycle progression, cell proliferation 
and survival (Fig.2).
Pyk2 pathway
　Pyk2 is a member of the FAK (focal adhesion 
kinase) family protein tyrosine kinase. Mi-
yazaki, et al. reported that IL-2 activates Pyk2 
which is associated and activated with JAK3 92). 
The kinase domain deleted mutant of Pyk2, 
blocked IL-2-mediated cell proliferation. How-
ever the downstream molecules of Pyk2 are 
still unknown.
IL-2 signaling
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Syk pathway
　Syk is a member of the ZAP70 family protein 
tyrosine kinases which are characterized by 
the presence of two SH2 domains. Generally 
Syk and ZAP70 are involved and have pivotal 
roles in BCR and TCR signaling pathway 
respectively. Syk is also associated with the S-
region of IL-2Rβ and activated by IL-2 
stimulation 93). Cross-linking of membrane an-
choring type of Syk mutant leads to c-myc gene 
induction.
mTOR (the mammalian target of rapamycin)
　Rapamycin, a lipophilic macrolide antibiot-
ics, inhibits IL-2-induced T cell proliferation in 
the late G1 phase. Rapamycin works on a 
serine/threonine kinase, mTOR as a complex 
with FKBP12 and inhibits mTOR activity. One 
possible target of mTOR is PHAS-1 which is 
involved in the regulation of protein transla-
tion94). Another molecule that is activated 
through mTOR is p70S6 kinase which 
phosphorylates S6 ribosomal protein and 
regulates the translation95). These findings 
suggest that rapamycin interacts with the 
translational regulator protein and inhibits its 
function. So rapamycin may inhibit IL-2-
mediated signal transduction at the transla-
tional level.
STAM (signal transducing adaptor mole-
cule) and Hgs/Hrs (HGF-regulated tyro-
sine kinase substrate)
　In the IL-2-induced signaling, several protein
 are phosphorylated on tyrosine residues. 
Among these phosphoproteins, STAM and Hgs 
were purified and their cDNA were cloned as 
novel molecules 96)-98). STAM has an SH3 
domain and a tyrosine cluster region with an 
ITAM (immunoreceptor tyrosine-based activa-
tion motif). STAM is found to be associated 
with JAK2 and JAK3 and phosphorylated with 
not only IL-2, but also many other cytokines 
which activate JAK2 or JAK3 99)(Fig.2). 
Hgs/Hrs has FYVE finger domain, localizes to 
early endosomes and thought to be implicated 
in vesicular trafficking 100)-103). Because STAM 
and Hgs/Hrs are associated with their coiled-
coil motifs to each other 98), STAM may play 
some roles not only in the downstream of 
JAKs, but also in vesicular transport. 
CONCLUSIONS
　IL-2-binding to the receptors causes confor-
mational change of the receptors followed by 
the kinases recruitment including JAK1, JAK3 
and other tyrosine kinases such p56lck, Pyk2 
and Syk. These tyrosine kinases are activated 
by each other and conduct many orchestrated 
downstream signals. Activated kinases phos-
phorylate tyrosine residues on the receptors as 
a trigger of downstream signal cascades. Many 
downstream messenger molecules like STATs, 
Shc, PI3K, which possess SH2 domain, bind on 
the tyrosine-phosphorylated receptors and are 
activated, and then transduce signals to 
nucleus directly, or through Ras-ERK1/2 
kinases or Akt kinase, respectively. However, 
further work is needed to clear how multiple 
kinase triggered-multiple signaling cascades 
cooperate with each other and regulate gene 
induction for cell growth, survival, differentia-
tion or cell death.
　We thank Lishomwa C. Ndhlovu for reading 
the manuscript and making many helpful 
suggestions.
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